A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.

Clinical Trial Description

This study seeks to examine a potential relationship between CTCF genotype and hemangioma size and growth rate. In addition to the initial visit, patients will return to our clinic for evaluation at two weeks, one month, two months, six months, and one year. At each visit, patients' hemangiomas will be measured and photographed. At one point over the course of evaluation, a blood sample will be taken from each patient for evaluation of C/T polymorphism at CTCF binding site six. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00974129
Study type	Observational
Source	Yale University
Contact
Status	Withdrawn
Phase	N/A
Start date	September 2009
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01685398` - Topical Timolol for Superficial Infantile Hemangioma	Phase 3
Completed	`NCT00374335` - Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas	N/A
Recruiting	`NCT03331744` - Clinical Characteristics of Infantile Hemangioma
Completed	`NCT02342275` - Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma	Phase 3
Completed	`NCT00433940` - Immune Suppression Of Infants Treated With Steroids	N/A
Completed	`NCT04065217` - The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial	N/A
Terminated	`NCT01743885` - Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma	Phase 3
Terminated	`NCT00555464` - Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas	Phase 2
Completed	`NCT00394888` - Hemangioma Associated With High Rates of Morbidity	N/A
Completed	`NCT05327309` - Role of Propranolol as Compared to Bleomycin in Management of Hemangioma	N/A
Completed	`NCT02145884` - Topical Timolol Gel for the Treatment of Infantile Hemangiomas	Phase 2
Completed	`NCT04077515` - Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma	Phase 4
Completed	`NCT02731287` - Topical Timolol for Infantile Hemangioma in Early Proliferative Phase	Phase 2
Recruiting	`NCT01147601` - Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas	Phase 0
Completed	`NCT01908972` - The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma	Phase 4
Completed	`NCT00540566` - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed	`NCT00001417` - Direct Injection of Alcohol for the Treatment of Spinal Tumors	N/A
Completed	`NCT00004436` - Randomized Study of Hormonal Regulation of Infantile Hemangioma	N/A
Recruiting	`NCT02496013` - Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB	Phase 1
Completed	`NCT01072045` - Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma	Phase 2